High Tide Inc. filings document its disclosures as a Canadian foreign issuer operating in cannabis retail, e-commerce accessories, hemp-derived CBD and international medical cannabis distribution. Form 6-K reports furnish company news releases covering Canna Cabana store activity, operating and financial results, subsidiary developments, insider share purchases, common-share trading matters, and financing arrangements.
The filing record also includes governance and compensation materials, including an amended statement of executive compensation. High Tide disclosures address its common-share capital structure, senior credit arrangements, executive and director compensation, board and management oversight, ownership information, material events, and risk-related topics connected to regulated cannabis markets in Canada, the United States and Germany.
High Tide Inc. filed a Form 6-K highlighting the opening of a new Canna Cabana retail cannabis store in Caledonia, Ontario. The store at 345 Argyle Street South began selling recreational cannabis and accessories for adult use on April 20, 2026, bringing the Canna Cabana network to 221 locations across Canada, including 97 in Ontario.
The Caledonia store is located at the south end of town in a busy commercial node alongside a pharmacy, liquor store, and national retailers, targeting a growing trade area with strong household incomes. CEO Raj Grover framed the 4/20 opening as a symbolic milestone as the brand approaches eight years since its first Canna Cabana store, positioning the launch as part of a disciplined national scaling strategy.
High Tide Inc. filed a Form 6-K announcing that its senior executives and advisors will speak on panels at multiple cannabis and investor conferences across North America and Europe from April to June 2026.
The company describes itself as a leading retail-forward cannabis enterprise, with its Canna Cabana chain operating 220 Canadian stores and 1 international location and holding a 12% share of the Canadian market. Its German subsidiary, Remexian Pharma GmbH, is licensed to import medical cannabis from 19 countries.
High Tide Inc. reports that its U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, is pursuing participation in the U.S. Centers for Medicare & Medicaid Services Innovation Center’s Beneficiary Engagement Incentive pilot program. The pilot, launching April 1, 2026, allows certain Medicare model participants to furnish eligible hemp-derived CBD products to beneficiaries at no cost, up to US$500 per year per beneficiary, with costs borne by participating organizations.
NuLeaf Naturals, founded in 2014 and operating cGMP-certified, FDA-registered facilities, believes its THC-free and broad-spectrum CBD products align with the program’s compliance requirements. High Tide views this pilot as a potential growth driver for its U.S. CBD business while continuing advocacy through the National Compassionate Care Council.
High Tide Inc. reported strong first fiscal quarter 2026 results, with revenue of $178,329 thousand, up 25% from $142,461 thousand a year earlier. Gross profit also rose 25% to $44,409 thousand, keeping gross margin steady at 25%, showing the business is growing while maintaining pricing and cost discipline.
Adjusted EBITDA improved to $11,457 thousand, a 62% increase from $7,089 thousand, and Adjusted EBITDA margin edged up to 6%. Net loss narrowed significantly to $352 thousand from $2,689 thousand, and basic and diluted income (loss) per share improved to $0.01 from $(0.03).
Cash generation improved meaningfully. Net cash provided by operating activities was $5,860 thousand versus $683 thousand, and free cash flow swung to a positive $2,939 thousand from negative $1,900 thousand. Management highlighted record revenue exceeding $700 million annualized, continued expansion of Canna Cabana’s 220-store Canadian network, growing German medical cannabis sales through Remexian, and recovering U.S. e-commerce trends.
High Tide Inc. reported much stronger results for the quarter ended January 31, 2026. Revenue rose 25% to $178.3M, driven mainly by Canadian bricks-and-mortar sales of $149.7M and medical cannabis distribution revenue of $25.0M from Remexian in Germany.
Gross profit increased 25% to $44.4M, maintaining a 25% gross margin. Income from operations improved to $2.4M from $0.1M, while the net loss narrowed to $0.4M. Adjusted EBITDA grew 62% to $11.5M, and free cash flow swung to a positive $2.9M from a $1.9M outflow.
The company ended the quarter with total assets of $346.4M, shareholders’ equity of $102.0M, and cash and restricted cash of $46.4M. High Tide operated 218 Canadian retail stores as of January 31, 2026 and highlighted rapid growth in its Cabana Club and Elite loyalty programs.
High Tide Inc. filed a report highlighting the opening of its 220th Canna Cabana cannabis store, located on London Road in Sarnia, Ontario, which will start selling adult-use products on March 9, 2026. This is the Company’s first store in Sarnia and its 96th location in Ontario.
High Tide also announced it will release financial and operational results for the quarter ended January 31, 2026 after markets close on March 17, 2026, followed by a webcast on March 18, 2026 with its CEO and CFO to discuss the results and outlook.
High Tide Inc. filed a Form 6-K highlighting that it and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals have joined the U.S. National Compassionate Care Council as founding members. The Council focuses on improving patient access to cannabinoid therapies through modernized, evidence-based healthcare standards.
Management notes that recent U.S. federal initiatives to reschedule cannabis and explore Medicare reimbursement for hemp-derived cannabinoid products could materially affect High Tide’s American CBD operations. The filing also profiles High Tide’s broader business, including its 219-location Canna Cabana retail chain with a 12% Canadian market share and its German medical cannabis distributor Remexian Pharma.
High Tide Inc. reported board and leadership changes alongside new equity awards. Two long-serving directors, Nitin Kaushal and Andrea Elliott, resigned effective March 2, 2026, and were replaced by Kathleen Skerrett, a securities and governance lawyer, and technology entrepreneur Menashe Kestenbaum.
The company also added David Wallach and Filip Ernest to its Advisory Board to guide real estate, business development, artificial intelligence, e-commerce and stakeholder initiatives. To align incentives, High Tide granted 123,558 restricted stock units and 25,000 stock options, each option exercisable at $3.43 per share for three years, under its omnibus equity plan and subject to statutory holding periods.
High Tide Inc. filed a 6-K highlighting operational expansion and new equity incentives. The company opened a new Canna Cabana retail cannabis store at 3148 Kingston Road in Scarborough, Ontario, bringing its network to 219 Canna Cabana locations across Canada and 95 in Ontario. Management describes the site as a high-traffic corridor with limited nearby cannabis competition and a history of strong retail performance.
High Tide also granted 145,500 stock options exercisable at $3.22 per share until February 6, 2029, vesting over two years, and 1,300,530 restricted stock units to directors, officers, employees, and consultants. Of the RSUs, 48% vest on February 6, 2027, 26% on February 6, 2028, and the remaining 26% on February 6, 2029. Directors received an aggregate of 795,106 RSUs, treated as a related-party transaction under MI 61-101, but exempt from formal valuation and minority approval because the fair market value and consideration are each below 25% of the company’s market capitalization.
High Tide Inc., a Canadian cannabis retailer and accessories company listed on the TSX Venture Exchange and Nasdaq, filed Amendment No. 1 to its Annual Report on Form 40-F for the year ended October 31, 2025. The amendment mainly corrects typographical errors in several narrative sections and refiles two auditor consent exhibits that were missing signatures; all other disclosures from the original report remain unchanged.
High Tide reports 87,235,986 common shares outstanding as of October 31, 2025 and discloses total contractual obligations of about $214.5 million, primarily lease commitments, accounts payable, debentures, and a junior secured convertible loan. The company highlights extensive forward-looking information about planned growth, acquisitions, and financing facilities, along with detailed risk factors, including regulatory uncertainty around U.S. hemp-derived Delta-8 and Delta-9 products and potential impacts on U.S. listings. As a foreign private issuer and emerging growth company, High Tide uses IFRS, follows Canadian governance practices with some Nasdaq exceptions, has an independent audit committee with an identified financial expert, and currently has no off-balance sheet arrangements.